Lv1
60 积分 2025-06-30 加入
Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index (ASTER 70s): a randomised phase 3 trial
5个月前
已完结
Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: A meta-analysis of randomized clinical trials
6个月前
已完结
Intermittent versus continuous clodronate administration in postmenopausal women with low bone mass
6个月前
已完结
[The use of parenteral clodronate in elderly women with postmenopausal osteoporosis: compliance, effects on bone mineral density and on bone turnover]
6个月前
已关闭
Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis
7个月前
已完结
Reassessment of Fracture Risk in Women After 3 Years of Treatment With Zoledronic Acid: When is it Reasonable to Discontinue Treatment?
7个月前
已完结
Novel insights into actions of bisphosphonates on bone: Differences in interactions with hydroxyapatite
7个月前
已完结
Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
7个月前
已完结
The Effect of Three or Six Years of Denosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the FREEDOM Extension
7个月前
已完结
10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
7个月前
已完结
皖公网安备34019202002308
